Stay updated on KN026 in Metastatic Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the KN026 in Metastatic Breast Cancer Clinical Trial page.

Latest updates to the KN026 in Metastatic Breast Cancer Clinical Trial page
- Check6 days agoChange DetectedAdded Revision: v3.4.2; removed Revision: v3.4.1; and replaced a government funding status notice. These changes affect page presentation and status messaging but do not alter trial data, eligibility, or outcomes shown on the page.SummaryDifference0.5%

- Check13 days agoChange DetectedA government funding status notice and an NIH operating status banner were added, and the site revision note was updated to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check20 days agoChange DetectedIntroduced Show glossary option and Revision: v3.4.0. Updated the QC-related label to 'Last Update Submitted that Met QC Criteria' and standardized capitalization for No FEAR Act data.SummaryDifference0.2%

- Check42 days agoChange DetectedThe last known status line now indicates Jiangsu Alphamab Biopharmaceuticals Co., Ltd as of September 2023, with status marked as Verified and Unknown.SummaryDifference0.4%

- Check56 days agoChange DetectedAdded Heilongjiang as a Location (Harbin, Heilongjiang, China) and removed the prior Heilongjiang Locations entry; page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check78 days agoChange DetectedThe page revision metadata now shows v3.3.2 as the current revision, replacing v3.3.1. No substantive content or study details appear to be affected.SummaryDifference0.1%

Stay in the know with updates to KN026 in Metastatic Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN026 in Metastatic Breast Cancer Clinical Trial page.